Medifast (MED) Misses Q1 EPS by 84c, Guidance Misses
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $11.12 +1.46%
EPS Growth %: -295.5%
Financial Fact:
Interest income/ (expense), net: 60K
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: -295.5%
Financial Fact:
Interest income/ (expense), net: 60K
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q1 EPS of $0.66, $0.84 worse than the analyst estimate of $1.50. Revenue for the quarter came in at $174.7 million versus the consensus estimate of $205.79 million.
GUIDANCE:
Medifast sees Q2 2024 EPS of $0.05-$0.40, versus the consensus of $0.67. Medifast sees Q2 2024 revenue of $150-170 million, versus the consensus of $175.1 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Retail investors largely unaware of SEC semiannual reporting proposal
- Morgan Stanley Resumes Bath & Body Works Inc. (BBWI) at Equalweight
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
